刘晶
博士研究生
进组时间: 2021
教育经历
• Liu J *, Shen L, Tang G, Tang S, Kuang W, Li H, Tian Y, Zhou Q. Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review. J Int Med Res . 2020 Jun;48(6):300060520930459.
• Tang G, Liu J , Gao X, Tang W, Chen J, Wu M, Lv Z, Zhang Y, Cai Y, Qi L. circWSB1 promotes tumor progression in ccRCC via circWSB1/miR-182-5p/WSB1 axis. Int J Biol Macromol . 2024 Jan;256(Pt 1):128338.
• Tang G, Liu J , Qi L, Li Y. The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma. Br J Clin Pharmacol . 2023 Jan;89(1):93-113.
• Tang R, Liu J , Li S, Zhang J, Yu C, Liu H, Chen F, Lv L, Zhang Q, Yuan K, Shao H. A patent and literature review of CDK12 inhibitors. Expert Opin Ther Pat . 2022 Oct;32(10):1055-1065.
• Tang G, Qi L, Sun Z, Liu J , Lv Z, Chen L, Huang B, Zhu S, Liu Y, Li Y. Evaluation and analysis of incidence and risk factors of lower extremity venous thrombosis after urologic surgeries: A prospective two-center cohort study using LASSO-logistic regression. Int J Surg . 2021 May;89:105948.
2013.9-2018.6：吉林大学 临床医学院 临床医学学士
2018.9-2021.6：中南大学 湘雅医院 放射肿瘤学硕士
2021.9-至今： 中南大学 湘雅医院 肿瘤学博士在读
肿瘤细胞生物学
中南大学校优秀学生（2022，2020）
中南大学湘雅医院优秀共产党员（2019）
吉林大学校优秀毕业生（2018）
国家励志奖学金（2017，2016，2015）
吉林大学校优秀学生（2016）
吉林大学白求恩医学院优秀学生（2017，2015）
科研项目
国家自然科学基金面上项目（32370821） 参与 （2024-2027）
湖南省芙蓉实验室科技攻关项目（2023SK2091） 参与 （2023-2025）
论文发表
• Liu J *, Tang G, Zhou Q, Kuang W. Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy. Radiat Oncol . 2022 Aug 17;17(1):142.• Liu J *, Shen L, Tang G, Tang S, Kuang W, Li H, Tian Y, Zhou Q. Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review. J Int Med Res . 2020 Jun;48(6):300060520930459.
• Tang G, Liu J , Gao X, Tang W, Chen J, Wu M, Lv Z, Zhang Y, Cai Y, Qi L. circWSB1 promotes tumor progression in ccRCC via circWSB1/miR-182-5p/WSB1 axis. Int J Biol Macromol . 2024 Jan;256(Pt 1):128338.
• Tang G, Liu J , Qi L, Li Y. The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma. Br J Clin Pharmacol . 2023 Jan;89(1):93-113.
• Tang R, Liu J , Li S, Zhang J, Yu C, Liu H, Chen F, Lv L, Zhang Q, Yuan K, Shao H. A patent and literature review of CDK12 inhibitors. Expert Opin Ther Pat . 2022 Oct;32(10):1055-1065.
• Tang G, Qi L, Sun Z, Liu J , Lv Z, Chen L, Huang B, Zhu S, Liu Y, Li Y. Evaluation and analysis of incidence and risk factors of lower extremity venous thrombosis after urologic surgeries: A prospective two-center cohort study using LASSO-logistic regression. Int J Surg . 2021 May;89:105948.